Cigarette smoking and other risk factors in relation to p53 expression in breast cancer among young women

Cancer Epidemiology Biomarkers and Prevention

Volumn 8, Issue 3, 1999, Pages 255-263

  Gammon, Marilie D ^a   Hibshoosh, Hanina ^b   Terry, Mary Beth ^a   Bose, Shikha ^b   Schoenberg, Janet B ^c   Brinton, Louise A ^d   Bernstein, Jonine L ^e   Thompson, W Douglas ^f  

^a Division of Epidemiology ^*  (United States)

^b Department of Pathology ^*  (United States)

^c Special Epidemiology Program   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e MOUNT SINAI MEDICAL CENTER   (United States)

^f UNIVERSITY OF SOUTHERN MAINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; RISK FACTOR;

ADULT; BEDDING AND LINENS; BEDS; BREAST NEOPLASMS; CARCINOGENS; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; EDUCATIONAL STATUS; EPIDEMIOLOGIC STUDIES; ETHNIC GROUPS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; MUTATION; ODDS RATIO; POPULATION SURVEILLANCE; REPRODUCTIVE HISTORY; RISK FACTORS; SMOKING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032943215     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Allred, D. C., Elledge, R., Clark, G. M., and Faqua, A. W. Mammary tumorigenesis and malignant progression. In: R. Dickson and M. Lippman (eds.), The p53 Suppressor Gene in Human Breast Cancer, pp. 63-77. Boston: Kluwer Academic, 1994.
2. Harris, C. C., and Hollstein, M. Clinical implications of the p53 tumor-suppressor gene. N. Engl. J. Med., 329: 1318-1327, 1993.
3. Harris, C. C. Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J. Natl. Cancer Inst., 88: 1442-1455, 1996.
4. Volgelstein, B., and Kinzler, K. W. Carcinogens leave fingerprints. Nature (Lond.), 355: 209-210, 1992.
5. Lasky, T., and Magder, L. Hepatocellular carcinoma p53 G→T transversions at codon 249: the fingerprint of aflatoxin exposure? Environ. Health Perspect., 105: 392-397, 1997.
6. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. Mutation in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994.
7. Biggs, P. J., Warren, W., Venitt, S., and Stratton, M. R. Does a genotoxic carcinogen contribute to human breast cancer? The value of mutational spectra in unraveling the aetiology of cancer. Mutagenesis, 8: 275-283, 1993.
8. Harris, C. C. Deichmann Lecture-p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology and cancer risk assessment. Toxicol. Lett., 82-83: 1-7, 1995.
9. Tsuda, H., and Hirohashi, S. Association among p53 gene mutation, nuclear accumulation of the p53 protein and aggressive phenotypes in breast cancer. Int. J. Cancer. 57: 498-503, 1994.
10. Iggo, R., Gatter, K., Barter, J., Lane, D., and Harris, A. L. Increase expression of mutant forms of p53 oncogene in primary lung cancer. Lancet. 335: 675-679, 1990.
11. Taylor, J. A., Sandler, D. P., Bloomfield, C. D., Shore, D. L., Ball, E. D., Neubauer, A., McIntyre, O. R., and Liu, E. Ras oncogene activation and occupational exposures in acute myeloid leukemia. J. Natl. Cancer Inst., 84: 1626-1632, 1992.
12. Brinton, L. A., Daling, J. R., Liff, J., Schoenberg J. B., Malone, K. E., Stanford, J. L., Coates, R. J., Gammon, M. D., Hanson, L. H. R. Oral contraceptives and breast cancer risk among younger women. J. Natl. Cancer Inst., 87: 827-835, 1995.
13. Brinton, L. A., Potischman, N. A., Swanson, C. A., Schoenberg, J. B., Coates, R., Gammon, M. D., Malone, K. E., Stanford, J. L., and Daling, J. R. Breastfeeding and breast cancer risk. Cancer Causes Control, 6: 199-208, 1995.
14. Swanson, C. A., Coates, R. J., Malone, K. E., Gammon, M. D., Schoenberg, J. B., Brogan, D. J., McAdams, M., Potischman, N., Hoover, R. N., and Brinton, L. A. Alcohol consumption and breast cancer risk among women under age 45. Epidemiology, 8: 231-237, 1997.
15. Swanson, C. A., Coates, R. J., Schoenberg, J. B., Malone, K. E., Gammon, M. D., Stanford, J. L., Shorr, I. J., Potischman, N. A., and Brinton, L. A. Body size and breast cancer risk among women under age 45 years. Am. J. Epidemiol., 143: 698-706, 1996.
16. Gammon, M. D., Schoenberg, J. B., Teitelbaum, S. L., Brinton, L. A., Potischman, N., Swanson, C. A., Brogan, D. J., Coates, R. J., Malone, K. E., and Stanford, J. L. Cigarette smoking and breast cancer risk among young women. Cancer Causes Control, 9: 583-590, 1998.
17. Waksberg, J. Sampling methods for random digit dialing. J. Am. Stat. Assoc., 73: 40-46, 1978.
18. Taylor, C. R., Shi, S-R., Chaiwum, B., Young, L., Iman, S. A., and Cote, R. J. Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections. Hum. Pathol., 25: 263-270, 1994.
19. Poller, D. N., Roberts, E. C., Bell, J. A., Elston, C. W., Blamey, R. W., and Ellis, I. O. p53 protein expression in mammary ductal carcinoma in situ. Hum. Pathol., 24: 463-468, 1993.
20. Hosmer, D. W., and Lemenshow, S. Applied logistic regression. New York: John Wiley & Sons, 1989.
21. Willett, W., and Stampfer, M. J. Total energy intake: implications for epidemiologic analyses. Am. J. Epidemiol., 124: 17-27, 1986.
22. Sjorgren, S., Inganas, M., Norberg, T., Lindgren, A., Nordgren, H., Holmberg, L., and Bergh, J. The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J. Natl. Cancer Inst., 88: 173-182, 1996.
23. Thor, A. D., Moore, D. H., II, Edgerton, S. M., Kawasaki, E. S., Reihsaus, E., Lynch, H. T., Marcus, J. N., Schwartz, L., Chen, L. C., and Mayall, B. H. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancer. J. Natl. Cancer Inst., 84: 845-855, 1992.
24. Jacobs, T., Prioleau, J. E., Stillman, I. E., and Schnitt, S. J. Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J. Natl. Cancer Inst., 88: 1054-1059, 1996.
25. Manne, U., Myers, R. B., Srivastava, S., and Grizzle, W. E. Re: Loss of tumor marker-immunostaining intensity on stored paraffin slides of beast cancer. J. Natl. Cancer Inst., 89: 585-586, 1997.
26. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. p53 mutations in human cancers. Science (Washington DC), 253: 49-52, 1991.
27. van der Kooy, K., Rookus, M. A., Peterse, H. L.. and van Leeuwen, F. E. p53 protein overexpression in relation to risk factors for breast cancer. Am. J. Epidemiol., 144: 924-933, 1996.
28. Terry, M. B., Gammon, M. D., Ng-Mak, D., and Thompson, W. D. Bias from misclassification of p53 status. Am. J. Epidemiol., 147: 511-512, 1998.
29. Rosen, P. P., Lesser, M. L., Arroyo, C. D., Cranor, M., Borgen, P., and Norlon, L. p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis. J. Clin. Oncol., 13: 821-830, 1995.
30. Baron, J. A., Newcomb, P. A., Longnecker, M. P., Mittendorf, R., Storer, B. E., Clapp, R. W., Bogdan, G., and Yuen, J. Cigarette smoking and breast cancer. Cancer Epidemiol. Biomark. Prev., 5: 399-403, 1996.
31. Smith, S. J., Deacon, J. M., Chilvers, C. E. D., and members of the UK National Case-Control Study Group. Alcohol, smoking, passive smoking and caffeine in relation to breast cancer risk in young women. Br. J. Cancer, 70: 112-119, 1994.
32. Ewertz, M. Smoking and breast cancer risk in Denmark. Cancer Causes Control, 1: 31-37, 1990.
33. London, S. J., Colditz, G. A., Stampfer, M. J., Willett, W. C., Rosner, B. A., and Speizer, F. E. Prospective study of smoking and the risk of breast cancer. N. Engl. J. Med., 81: 1625-1631, 1989.
34. Adami, H-O., Lund, E., Bergstrom, R., and Meirik, O. Cigarette smoking, alcohol consumption and risk of breast cancer in young women. Br. J. Cancer, 58: 832-837, 1988.
35. McCredie, M. R. E., Dite, G. S., Giles, G. G., and Hopper, J. L. Breast cancer in Australian women under the age of 40. Cancer Causes Control, 9: 189-198, 1993.
36. Vessey, M., Baron, J., Doll, R., McPherson, K., and Yeates, D. Oral contraceptives and breast cancer: final report of an epidemiological study. Br. J. Cancer, 47: 455-462, 1983.
37. Meara, J., McPherson, K., Roberts, M., Jones, L., and Vessey, M. Alcohol, cigarette smoking and breast cancer. Br. J. Cancer, 60: 70-73, 1989.
38. O'Connell, D. L., Hulka, B. S., Chambless, L. E., Wilkinson, W. E., and Deubner, D. C. Cigarette smoking, alcohol consumption, and breast cancer risk. J. Natl. Cancer Inst., 78: 229-234, 1987.
39. Vatten, L. J., and Kvinnsland, S. Cigarette smoking and risk of breast cancer: a prospective study of 24 329 Norwegian women. Eur. J. Cancer, 26: 830-833, 1990.
40. Palmer, J. R., Rosenberg, L., Clark, E. A., Stolley, P. D., Warshauer, M. E., Zauber, A. G., and Shapiro, S. Breast cancer and cigarette smoking: a hypothesis. Am. J. Epidemiol., 134: 1-13, 1991.
41. Calle, E. E., Miracle-McMahill, H. L., Thun, M. J., Heath, C., Jr. Cigarette smoking and risk of fatal breast cancer. Am. J. Epidemiol., 139: 1001-1007, 1994.
42. Rautalahti, M., Albanes, D., Virtamo, J., Palmgren, J., Haukka, J., and Heinonen, O. P. Lifetime menstrual activity-indicator of breast cancer risk. Eur. J. Epidemiol., 9: 17-25, 1993.
43. Schechter, M. T., Miller, A. B., and Howe, G. R. Cigarette smoking and breast cancer: a case-control study of screening program participants. Am. J. Epidemiol., 121: 479-487, 1985.
44. Chu, S. Y., Stroup, N. E., Wingo, P. A., Lee, N. C., Peterson, H. B., and Gwinn, M. L. Cigarette smoking and the risk of breast cancer. Am. J. Epidemiol., 131: 244-253, 1990.
45. Rohan, T. E., and Baron. J. A. Cigarette smoking and breast cancer. Am. J. Epidemiol., 129: 36-42, 1989.
46. van Leeuwen, F. E., de Vries, F., van der Kooy, K., and Rookus, M. Smoking and breast cancer risk. Am. J. Epidemiol., 145: S29, 1997.
47. Baron, J. A., La Vecchia, C., and Levi, F. The antiestrogenic effect of cigarette smoking in women. Am. J. Obstet. Gynecol., 162: 502-514, 1990.
48. Ambrosone, C. B., Freudenheim, J. L., Graham, S., Marshall, J. R., Vena, J. E., Brasure, J. R., Michalek, A. M., Laughlin, R., Nemoto, T., Gillenwater, K. A., Harrington, A. M., and Shields, P. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. J. Am. Med. Assoc., 276: 1494-1501, 1996.
49. Semenza, J. C., and Weasel, L. H. Molecular epidemiology in environmental health: the potential of tumor suppressor gene p53 as a biomarker. Environ. Health Perspect., 105 (Supp. 1); 155-163, 1997.
50. Esposito, V., Baldi, A., De Luca, A., Micheli, P., Mazzarella, G., Baldi, F., Caputi, M., and Giordano, A. Prognostic value of p53 in non-small cell lung cancer: relationship with proliferating cell nuclear antigen and cigarette smoking. Hum. Pathol., 28: 233-237, 1997.
51. Wang, X., Christiani, D. C., Wiencke, J. K., Fischbein, M., Xu, X., Cheng, T. J., Mark, E., Wain, J. C., and Kelsey, K. T. Mutations in the p53 gene in lung cancer are associated with cigarette smoking and asbestos exposure. Cancer Epidemiol. Biomark. Prev., 4: 543-548, 1995.
52. Husgafvel-Pursiainen, K., Ridanpaa, M., Anttila, S., and Vainio, H. p53 and ras gene mutations in lung cancer: implications for smoking and occupational exposures. J. Occup. Environ. Med., 37: 69-76, 1995.
53. Husgafvel-Pursiainen, K., and Kanno, A. Cigarette smoking and p53 mutations in lung cancer and bladder cancer. Environ. Health Perspect., 104 (Suppl. 3): 553-556, 1996.
54. Kawajiri, K., Eguchi, H., Nakachi, K., Sekiya, T., and Yamamoto, M. Association of CYP1A1 germ line polymorphism with mutations of the p53 gene in lung cancer. Cancer Res., 56: 72-76, 1996.
55. Claus, E. B., Schildkraut, J. M., Thompson, W. D., and Risch, N. J. The genetic attributable risk fo breast and ovarian cancer. Cancer (Phila.), 77: 2318-2324, 1996.
56. Crook, T., Crossland, S., Crompton, M. R., Osin, P. G. B. p53 mutations in BRCA1-associated familial breast cancer. Lancet, 350: 638-639, 1997.
57. Gretarsdottier, S., Thorlacisu, S., Valgardsdottir, R., Gudlaugsdottir, S., Sigurdsson, S., Steinarsdottir, M., Jonasson, J. G., Anamthawat-Jonsson, K., and Eyfjord, J. E. BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability. Cancer Res., 58: 589-562, 1998.
58. Ega, K. M., Newcomb, P. A., Longnecker, M. P., Trentham-Dietz, A., Baron, J. A., Trichopolous, D., Stampfer, M. J.. and Willett, W. C. Jewish religion and risk of breast cancer. Lancet, 347: 1645-1646, 1996.
59. Stevens, R. G., Davis, S., Thomas, D. B., Anderson, L. E., and Wilson, B. W. Electric power, pineal function, and risk of breast cancer. Am. J. Epidemiol., 6: 853-860, 1992.
60. Guenel, P., Raskmark, P., Andersen, J. B., and Lynge, E. Incidence of cancer in persons with occupational exposure to electromagnetic fields in Denmark. Br. J. Indust. Med., 50: 758-764, 1993.
61. Loomis, D. P., Savitz, D. A., and Ananth, C. V. Breast cancer mortality among female electrical workers in the United States. J. Natl. Cancer Inst., 86: 921-925, 1994.
62. Tynes, T., Hannevik, M., Andersen, A., Vistnes, A. I., and Haldorsen, T. Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control, 7: 197-204, 1996.
63. Coogan, P. F., Clapp, R. W., Newcomb, P. A., Wenzl, T. B., Bogdan, G., Mittendorf, R., Baron, J. A., and Longnecker, M. P. Occupational exposure to 60-hertz magnetic fields and risk of breast cancer in women. Epidemiology, 7: 459-464, 1996.
64. Wertheimer, N., and Leeper, E. Magnetic field exposure related to cancer subtypes. Ann. NY Acad. Sci., 502: 43-54, 1987.
65. McDowall, M. E. Mortality of persons resident in the vicinity of electricity transmission facilities. Br. J. Cancer, 53: 271-279, 1986.
66. Schreiber, G. H., Swaen, G. M. H., Meijers, J. M. M., Slangen, J. J. M., and Sturmans, F. Cancer mortality and residence near electricity transmission equipment: a retrospective cohort study. Int. J. Epidemiol., 22: 9-15, 1993.
67. Li, C-Y., Theriault, G., and Lin, R. S. Residential exposure to 60-hertz magnetic fields and adult cancers in Taiwan. Epidemiology, 8: 25-30, 1997.
68. Vena, J. E., Graham, S., Hellman, R., Swanson, M., and Brasure, J. Use of electric blankets and risk of postmenopausal breast cancer. Am. J. Epidemiol., 134: 180-185, 1991.
69. Vena, J. E., Freudenheim, J. L., Marshall, J. R., Laughlin, R., Swanson, M., and Graham, S. Risk of premenopausal breast cancer and use of electric blankets. Am. J. Epidemiol., 140: 974-979, 1994.
70. Vena, J. E., Marshall, J. R., Freudenheim, J. L., Swanson, M., and Graham, S. Re. "Risk of premenopausal breast cancer and use of electric blankets" The authors' reply. Epidemiology, 142: 446-447, 1995.
71. Gammon, M. D., Schoenberg, J. B., Britton, J. A., Kelsey, J. L., Stanford, J. L., Malone, K. E., Coates, R. J., Brogan, D. J., Potischman, N. A., Swanson, C. A., and Brinton, L. A. Electric blanket use and breast cancer risk among younger women. Am. J. Epidemiol., 148: 556-563, 1998.
72. Kelsey, J. L., and Bernstein, L. Epidemiology and prevention of breast cancer. Ann. Rev. Public Health, 17: 47-67, 1996.
73. Liberatos, P., Link, B. G., and Kelsey, J. L. The measurement of social class in epidemiology. Epidemiol. Rev., 10: 87-121, 1988.
74. Schildkraut, J. M., Bastos, E., and Berchuck, A. Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer. J. Natl. Cancer Inst., 89: 932-938, 1997.